Epidemiology and Genetics

 

 

This special collection of mini-review articles focuses on identifying trends in the evolving epidemiological and genetic landscape of endocrine-related tumours. It aims to enhance understanding of common and rare endocrine tumours across the medical, scientific and public health spaces.

These mini-reviews will emphasise the dual importance of epidemiology and molecular genetics, and in doing so, will act as an efficient and high-impact resource for researchers and clinicians alike. 

We look forward to expert contributions that crystallise current knowledge and advance the field of endocrine oncology. 
 
The Editors welcome submissions of mini-reviews to this collection with the following guidelines: 

  • manuscripts have a maximum word count of 3000 words
  • each mini-review must include a summary box that encapsulates all of the main information on epidemiology (incidence, prevalence, sex distribution, population risk groups), pathological disease classification, and main genetic types/subtypes
  • authors should include a single summary figure or graphical abstract that captures the essential epidemiological and genetic information described in the manuscript. 

For more information and to submit your proposal, please email eo@bioscientifica.com.

 

Collection Editors

Professor Patrick Petrossians MD, PhD, Associate Editor 
Professor Petrossians serves as the Head of the Endocrinology Department at the University Hospital of Liège (CHU de Liège) in Belgium and holds a Professorship in Endocrinology at the University of Liège. His primary research and publications focus on neuroendocrinology and pituitary disorders, with additional work in thyroid ultrasound imaging, including the publication of a specialised atlas in this area. Beyond his clinical and teaching roles, he is actively involved in IT and data mining applications within endocrinology. 
 

Dr Adrian F Daly

Dr Adrian F. Daly MD, PhD, Guest Editor 
Dr Daly is a Clinician-Scientist and Consultant Physician at the Centre Hospitalier Universitaire de Liège, Belgium, where he focuses on rare diseases in Endocrinology, Neuroendocrinology and Genetics. He takes a particular interest in the role of genetic factors in the pathophysiology and management of neuroendocrine diseases. Dr Daly played a key role in the discovery of the disease X-linked acrogigantism (X-LAG) and the characterisation of how GPR101 mis-expression due to 3D chromatin disruption leads to pituitary gigantism. He also had a central role in the description of Familial Isolated Pituitary Adenomas (FIPA), and the contribution of the AIP gene in aggressive forms of acromegaly and other pituitary tumours.